Table 4.
Regression analysis for risk of premature birth in SARS-CoV-2 infected pregnant women.
| Risk | (95% CI) | Significance | |
|---|---|---|---|
| Hazard Ratio | |||
| NLR | 3.61 | 1.94–6.15 | <0.001 |
| dNLR | 3.13 | 1.82–5.34 | <0.001 |
| PLR | 4.07 | 1.25–7.84 | <0.001 |
| MLR | 1.96 | 1.44–3.78 | 0.002 |
| SII | 1.50 | 0.94–1.45 | 0.134 |
| SIRI | 1.24 | 0.92–1.97 | 0.090 |
| Adjusted Odds Ratio * | |||
| NLR | 4.23 | 1.81–7.36 | <0.001 |
| dNLR | 3.09 | 1.72–5.94 | <0.001 |
| PLR | 5.65 | 2.30–8.05 | <0.001 |
| MLR | 2.17 | 1.39–2.51 | 0.046 |
| SII | 1.58 | 0.99–1.93 | 0.217 |
| SIRI | 1.66 | 0.89–1.87 | 0.195 |
CI—Confidence Interval; NLR—Neutrophil-Lymphocyte Ratio; dNLR—derived Neutrophil-Lymphocyte Ratio; PLR—Platelets-Lymphocyte Ratio; MLR—Monocytes-Lymphocyte Ratio; * Adjusted for BMI, smoking and COVID-19 infection status.